JW Holdings Corp
096760
Company Profile
Business description
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.
Contact
698 Sindaebang 1-dong
Dongjak-gu
Seoul156-010
KORT: +82 28406777
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
134
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,923.80 | 7.50 | -0.08% |
| CAC 40 | 8,124.88 | 56.26 | 0.70% |
| DAX 40 | 24,229.91 | 43.42 | 0.18% |
| Dow JONES (US) | 48,416.56 | 41.49 | -0.09% |
| FTSE 100 | 9,751.31 | 102.28 | 1.06% |
| HKSE | 25,628.88 | 347.91 | -1.34% |
| NASDAQ | 23,057.41 | 137.76 | -0.59% |
| Nikkei 225 | 50,168.11 | 668.44 | -1.31% |
| NZX 50 Index | 13,394.50 | 13.64 | -0.10% |
| S&P 500 | 6,816.51 | 10.90 | -0.16% |
| S&P/ASX 200 | 8,635.00 | 8.90 | -0.10% |
| SSE Composite Index | 3,867.92 | 21.42 | -0.55% |